Sun Phar­ma to ac­quire Check­point Ther­a­peu­tics and its an­ti-PD-L1 an­ti­body

Af­ter months of search­ing for a part­ner for its re­cent­ly ap­proved can­cer drug, Check­point Ther­a­peu­tics has in­stead se­cured a buy­er.

In­dia’s Sun Phar­ma is ac­quir­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER